Year: 2024

TORONTO, Dec. 12, 2024 (GLOBE NEWSWIRE) — Mega View Digital Entertainment Corp. (“Mega View” or the “Company”) (NEX: MVD.H) announces that the Company will be relying on CSA Coordinated Blanket Order 51-931 (the “Order”) for exemption from the requirements to send proxy-related materials (the “Meeting Materials”) for its upcoming annual general and special meeting being held on January 3, 2024 (the “Meeting”) due to the current delays and suspension of mail service in Canada due to the nationwide strike of the Canadian Union of Postal Workers that commenced on November 15, 2024 (the “Postal Strike”). The Company has satisfied all the conditions to rely, and is relying, on the exemption from the requirement to send proxy-related materials in the Order. The Meeting Materials are accessible on the Company’s SEDAR+ profile at www.sedarplus.ca...

Company to Submit Product Development Plan to Treat External Squamous Cell Carcinoma (SCC) in Horses TORONTO and PHILADELPHIA, Dec. 12, 2024 (GLOBE NEWSWIRE) — Medicus Pharma Ltd. (NASDAQ: MDCX) (TSXV: MDCX) (“Medicus” or the “Company”) is pleased to announce that its Investigational New Animal Drug (INAD File No.013880) has received Minor Use in Major Species Designation (“MUMS”) from the U.S. Food and Drug Administration (“FDA”) for its dissolvable Doxorubin-containing microneedle array (D-MNA) to treat external squamous cell carcinoma (SCC) in horses. The company received a notification from the FDA on December 9th 2024. MUMS is a status similar to Orphan Drug status for human drugs. It entitles the company to an extended 7-year period of exclusive marketing following approval or conditional approval,...

WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2023 Corporate Sustainability Report and related reporting framework disclosures. Themed “Advancing Impacts”, this newly reformatted report streamlines the company’s progress in advancing our sustainability strategy across six key impact areas: Products & Packaging, Operations, Talent, Supply Chain, Communities and Partnerships & Pathways. Also included in the 2023 Sustainability Report are detailed disclosures aligned with four key reporting frameworks: the Global Reporting Initiative (GRI) Standards, Sustainability Accounting Standards Board (SASB), United Nations Sustainable Development Goals (UN SDGs) and Task Force...

TORONTO, Dec. 12, 2024 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drone solutions, Drone-as-a-Service (DaaS), Quantum Computing solutions, and enterprise SaaS (Software-as-a-Service) solutions, today announces the launch of a Quantum Computing project for traffic optimization and weather forecasting using the company’s drones. The project, called Sky Traffic, was developed following interest received from a government client to use the company’s ZenaDrone 1000 drones to monitor vehicle traffic. The project will provide real-time traffic data to both the government agency and to drivers, with a goal of improving the precision, accuracy and speed of information to optimize functions such as traffic flows and routing, traffic...

Jupiter, FL, Dec. 12, 2024 (GLOBE NEWSWIRE) — SRM Entertainment, Inc. (Nasdaq: SRM) (the “Company,” or “SRM”), a leading provider of licensed merchandise and souvenirs, today announced a significant reorder of its popular Sip With Me cups from a premier marine life theme park in Abu Dhabi and the development of exclusive products for a groundbreaking year-round horror attraction in Las Vegas. These developments underscore SRM’s growth and strategic expansion into new markets and product categories. The reorder of Sip With Me cups comes less than a year after the grand opening of a marine life theme park and animal researching, rescue & rehabilitation center located on Yas Island in Abu Dhabi, the capital of the United Arab Emirates. This premier theme park, owned and operated by Miral Asset Management under a license...

JUPITER, Fla., Dec. 12, 2024 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or “the Company”) today announced an expected surge in revenue growth projected to exceed approximately 50% in Q4 2024 over Q3 of 2024. This projected performance is believed to be fueled by a combination of factors, including the rebranding of its flagship product, Sure Shot, which the Company believes has captured significant market share; strategic alliances with retailers, expanding the Company’s reach across the country; and the strategic sale of securities, providing crucial capital to fuel further growth. The Company believes these anticipated results are a testament to the Company’s strategic vision and execution. The Company expects an increase in revenue compared to the previous quarter, with projections indicating...

MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V., received regulatory approval from COFEPRIS for TAVALISSE® (fostamatinib disodium hexahydrate) for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. “Treating chronic ITP is challenging due to the disease’s diversity, making it difficult to predict individual patient responses to available treatments and not all patients can find an effective solution. The approval of fostamatinib by COFEPRIS offers physicians a new therapeutic alternative with an innovative mechanism...

Roseland, NJ, Dec. 12, 2024 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that the Company successfully integrated Recraft AI into their artificial intelligence solution for game developers and publishers, Gaxos Labs. “We are pleased to add another great tool into our Gaxos Labs ecosystem,” said Vadim Mats, CEO of Gaxos. “Game development is a labor-intensive process and the addition of tools that make the process simpler advances our goal of being the all-in-one artificial intelligence solution for game developers and publishers.” For more information, visit Gaxos Labs where you’ll find more information on Gaxos Labs and all it offers game developers and players. You can also follow Gaxos Labs...